Literature DB >> 17022067

Microarray-based comparative genomic hybridization analysis of Wolf-Hirschhorn syndrome in a fetus with deletion of 4p15.3 to 4pter.

Angel Chao1, Yun-Shien Lee, An-Shine Chao, Tzu-Hao Wang, Shuenn-Dyh Chang.   

Abstract

BACKGROUND: Wolf-Hirschhorn syndrome (WHS), caused by the deletion of a segment in chromosome 4, is characterized by mental and developmental defects. Clinical manifestations of WHS include intrauterine growth restriction, failure to thrive in the neonatal period that is present simultaneously with hypotonia, typical "Greek helmet" facial appearance, cleft lip and palate, mental deficiency, and seizures. CASE: We present a case of WHS with prenatal conventional cytogenetics of 46,XY,der(4)t(4;13)(p15.3;p11.2)pat. High-resolution mapping using microarray-based comparative genomic hybridization (array-CGH), including Affymetrix 10K arrays and cDNA microarrays, confirmed the loss of genes in the deleted region.
CONCLUSIONS: The correlation between these candidate genes and the phenotypes of WHS may expand our understanding of the defective development caused by 4p deletion. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 17022067     DOI: 10.1002/bdra.20314

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  2 in total

1.  Gene dosage change of TPTE and BAGE2 and breakpoint analysis in Robertsonian Down syndrome.

Authors:  Sheng-Wen Shaw; Chih-Ping Chen; Po-Jen Cheng; Tzu-Hao Wang; Jia-Woei Hou; Cheng-Tao Lin; Shuenn-Dhy Chang; Hsiao-Lin Hwa; Ju-Li Lin; An-Shine Chao; Yung-Kuei Soong; Fon-Jou Hsieh
Journal:  J Hum Genet       Date:  2007-12-12       Impact factor: 3.172

2.  Prenatal diagnosis of Wolf-Hirschhorn syndrome confirmed by comparative genomic hybridization array: report of two cases and review of the literature.

Authors:  Stavros Sifakis; Emmanouil Manolakos; Annalisa Vetro; Dimitra Kappou; Panagiotis Peitsidis; Maria Kontodiou; Antonios Garas; Nikolaos Vrachnis; Anastasia Konstandinidou; Orsetta Zuffardi; Sandro Orru; Ioannis Papoulidis
Journal:  Mol Cytogenet       Date:  2012-02-28       Impact factor: 2.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.